First Trust Mid Cap Growth AlphaDEX

Symbotic Inc. prices its 10 million Class A shares at $55 per share to raise $550 million

Madrigal Pharmaceuticals insiders sold $1,380,816 worth of shares

Madrigal Pharmaceuticals CEO Plans to Sell 2,400 Shares of Restricted Stock

Rosenblatt Raises Lumentum Holding's Target Price to $380

Symbotic Inc. Quarterly Revenue Growth Falls Short of Expectations, Stock Price Gaps Down

Wayfair Launches Renewable Energy Project

Galmed Pharmaceuticals Grants New Use Patent for ARAMCHOL in Combination with Madrigal Pharmaceuticals' REZDIFFRA

Guardant Health insiders sold $5.846 million worth of shares

Guardant Health Exec Monroe Terilyn J Sells $5.8M in Shares

Ciena to release FY2025 Q4 earnings on December 11 Pre-Market EST, forecast revenue USD 1.288 B, EPS USD 0.3266

Madrigal Pharmaceuticals CFO Reports on Stock Disposal

PTC Therapeutics CEO discloses exercising and returning stock

Jefferies downgrades Wayfair rating leading to stock decline

Wells Fargo Analyst Maintains Buy Rating for PTC Therapeutics

Giordano Maintains Symbotic Buy Rating with $75 Price Target

Truist Securities Reiterates Buy Rating on Wayfair

Brookfield Secures Financing to Support Collaboration with Bloom Energy on AI Factory

Bloom Energy's stock price rises as executive sells shares

Hecla Mining Company Emphasizes Its Leadership in Silver Mining

Cetera Investment Advisers Increased Holdings of Bloom Energy in Q2

SEVEN HILLS RLTY TR COM USD0.001 (S/R 04/12/2025)

SMX Security Matters

Polyrizon

Picard Medical

Synchronoss Tech

PharmaCyte Biotech

Q/C Tech

Rich Sparkle

Hoyne Bancorp

Tradr 2X Long ASTS Daily ETF

Russell Investments Group Ltd. increased its holdings in Dycom Industries by 16.5% in Q2. Analysts have given Dycom a consensus 'Buy' rating, with a target price of $371.25. Dycom's stock opened at $354.84, with a 52-week high of $364.40. The company reported strong quarterly earnings, beating estimates with $3.63 EPS and $1.45 billion revenue, up 14.2% year-over-year.

Market Beat

Russell Investments Group Ltd.

Dycom Industries

Russell Investments Group Ltd. Increases Stock Holdings in Dycom Industries, Inc. $DY

Symbotic Inc :SYMBOTIC ANNOUNCES PRICING OF PRIMARY AND SECONDARY OFFERING OF CLASS A COMMON STOCKSYMBOTIC INC - SHARES PRICED AT $55.00 EACH IN OFFERING

Reuters

Symbotic

Symbotic Prices Common Stock Offering at $55 Per Share

Guardant Health, Inc.'s common stock is subject to a lock-up agreement ending on December 5, 2025. The lock-up period lasts 31 days, from November 4 to December 5, 2025. During this time, directors and executive officers cannot sell or transfer shares without consent from Goldman Sachs & Co. LLC and Jefferies LLC, with specified exceptions.

marketscreener

Guardant Health

Certain Common Stock of Guardant Health, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025.

MDGL

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,380,816, According to a Recent SEC Filing

Madrigal Pharma

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,380,816, According to a Recent SEC Filing

CEO Sibold William John of Madrigal Pharmaceuticals Inc filed a Form 144 with the SEC to sell 2,400 restricted shares on December 4, 2025. The sale will be managed by Morgan Stanley Smith Barney LLC. Form 144 is required for selling restricted stock, allowing the owner to sell within 90 days of filing. The Washington Service offers insider trading analysis and data services.

CEO Sibold Files To Sell 2,400 Of Madrigal Pharmaceuticals Inc [MDGL]

CAPR

SNOW

QURE

LUMN

INTC

ASST

Symbotic(SYM) fell 17.4%, with a trading turnover 592.0 Million USD, and a year-to-date rose 155.1%. Build A Bear(BBW) fell 15.54%, with a trading turnover 76.7 Million USD, and a year-to-date rose 7.1%. Capricor Therap(CAPR) fell 15.22%, with a trading turnover 219.7 Million USD, and a year-to-date rose 84.1%.

- The Nasdaq Composite Index rose by 0.22%, with a year-to-date increase of 21.7%.  
- The S&P 500 Index increased by 0.11%, accumulating a 16.6% rise for the year, while the Dow Jones Index fell by 0.07%, with a 12.5% year-to-date gain.  
- Notable declines included Symbotic (SYM) down 17.4%, Build A Bear (BBW) down 15.54%, and Capricor Therapeutics (CAPR) down 15.22%, despite significant year-to-date gains for each.  

LB Select

Build A Bear

Capricor Therap

Snowflake

Uniqure

MBX Biosciences

Lumen Tech

Intel

Strive

Top 10 US Stock Losers (12.4)

Bloom Energy's stock surged 15.21% to $118.09 due to AI energy demand, macroeconomic improvements, and anticipated Federal Reserve policy shifts. The company's partnerships and a $2.5 billion convertible note boost its aggressive growth strategy. Lower borrowing costs from potential rate cuts enhance Bloom's capital expansion, making gigawatt-scale power projects more attractive. Benzinga Edge data highlights Bloom's strong Momentum and Growth scores, reflecting intense buying pressure.

fidelity

Bloom Energy

Why Bloom Energy Stock Surged Thursday

AI-linked energy stocks are experiencing a surge in bullish options activity. Oklo's call volumes have more than doubled, Nuscale has seen nearly 140,000 call options traded, and Bloom Energy has traded nearly 80,000 calls. Nvidia CEO Jensen Huang highlighted the potential for nuclear energy, adding to the speculative interest in these stocks.

Sherwoodnews

AI energy plays soar on an explosion of call buying

The robotics company is raising cash.

Why Symbotic stock tumbled this week

Symbotic Inc. announced the pricing of its public offering of 10 million shares of Class A common stock at $55 per share. The offering includes shares sold by the company and SVF Sponsor III LLC, an affiliate of SoftBank. Symbotic plans to use proceeds for general corporate purposes, while the Selling Securityholder will receive proceeds from their share sales. The offering is expected to close on December 8, 2025, with Goldman Sachs and Citigroup as lead managers.

StockTitan

Symbotic Announces Pricing of Primary and Secondary Offering of Class A Common Stock | SYM Stock News

Bloom Energy's stock (NYSE:BE) rose 7.9% to $110.5730, with a trading volume decline of 71%. Analysts have varied ratings, with HSBC upgrading to "strong-buy" and others setting target prices between $89 and $157. The company reported better-than-expected earnings, with a 57.1% revenue increase year-over-year. Insider trading saw sales by Satish Chitoori and Shawn Marie Soderberg. Institutional investors like Vanguard and Geode Capital have adjusted their positions in the company.

Bloom Energy (NYSE:BE) Trading Up 7.9%  - Here's What Happened

Bloom Energy rose 13.96%; GE Vernova LLC rose 5.70%, with a transaction volume of USD 1.294 billion; NuScale Power rose 13.58%, with a transaction volume of USD 551 million; NANO Nuclear Energy rose 8.88%, with a transaction volume of USD 494.5 million; Power Solutions rose 5.64%, with a market capitalization of USD 1.428 billion

Tracking Unusual Activity

U.S. Stock Market Midday Update: AI Data Center Power Demand Soars, Bloom Energy Stock Price Surges Nearly 14%